Wargovich/Zimba Study II – Evaluation of Euglenophycin in Extended Studies of Cancer Prevention and Therapy

Written By Jayson LaFrance

WARGOVICH/ZIMBA STUDY II – EVALUATION OF EUGLENOPHYCIN IN EXTENDED STUDIES OF CANCER PREVENTION AND THERAPY (MICHAEL WARGOVICH, Ph.D. & PAUL ZIMBA, Ph.D.)

JOURNAL ARTICLES:

  • Toxins, 2012 Evidence for Euglenophycin Occurrence in Saline Environments: Field and Laboratory Studies

  • Geology & Geosciences Journal, Special Issue, 2013 – Quantitative Mass Spectrometric Analysis and Post-Extraction Stability Assessment of the Euglenoid Toxin Euglenophycin

  • Marine Drugs Journal, Vol. 13, 2015 – Augmenting Anti-Cancer Natural Products with a Small Molecule Adjuvant

  • OncoTarget, Vol. 8, 2017 – Therapeutic Effects of the Euglenoid Ichthyotoxin, Euglenophycin, in Colon Cancer

Jayson LaFrance https://jaysonlafrance.com
Previous

Thomas I Study – Role of the Novel Membrane Progesterone Receptors (mPRs) in the Human Vascular System
Next

Wargovich/Zimba Study I – Euglenophycin Synthesis and Clinical Evaluation for Cancer Treatment